Lymph node metastasis was uncommon among clinically node-negative PTC patients without evidence of nodal involvement on USG and CT.

People live on average a little over two years after an mCRPC diagnosis. Find statistics here and learn how treatment ...

The following is a summary of “Application of interpretable machine learning algorithm to predict lymph node metastasis in cutaneous malignant melanoma,” published in the April 2025 issue of ...

A combination of pertuzimab and Enhertu can slow disease progression and improve survival in people with HER2-positive ...

The FDA has cleared Delcath Systems to start a phase 2 trial for Hepzato in liver-dominant metastatic breast cancer ... or disease outside the liver limited to the bone, lymph nodes, subcutaneous ...

T cell therapy called AIC100, which targets the ICAM-1 protein, demonstrated encouraging responses and an acceptable safety profile in patients with two types of advanced thyroid cancer, according to ...

This review explores the role of PET in imaging immune activation, particularly in oncology. 18F-FDG is widely used for assessing treatment response to immunotherapies and can demonstrate unique ...

M: Metastasis; N: Node; T: Tumor. Data from [21]. Neuroendocrine tumors have demonstrated an increase in incidence and prevalence over the past decades, partly due to increased awareness ...

Early-Life Exposure to Air and Light Pollution Linked to Increased Risk of Pediatric Thyroid Cancer Apr. 18, 2025 — A new study suggests that early-life exposure to two widespread environmental ...

Ho, MD, PhD, Geoffrey Beene Junior Faculty Chair at Memorial Sloan Kettering Cancer Center, discussed the latest developments in targeted therapies for thyroid cancer, the most important factors ...